Handelsbanken Fonder Ab Neogenomics Inc Transaction History
Handelsbanken Fonder Ab
- $26.2 Billion
- Q4 2024
A detailed history of Handelsbanken Fonder Ab transactions in Neogenomics Inc stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 28,300 shares of NEO stock, worth $381,767. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,300
Previous 25,200
12.3%
Holding current value
$381,767
Previous $372,000
25.27%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NEO
# of Institutions
296Shares Held
125MCall Options Held
698KPut Options Held
116K-
Black Rock Inc. New York, NY19.7MShares$265 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$189 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$92.9 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$89.1 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$88.2 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.7B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...